As of close of business last night, Enveric Biosciences Inc’s stock clocked out at $1.20, down -9.09% from its previous closing price of $1.32. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 634956 shares were traded. ENVB stock price reached its highest trading level at $1.3726 during the session, while it also had its lowest trading level at $1.1400.
Ratios:
To gain a deeper understanding of ENVB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 15 ’23 when PASQUALONE FRANK bought 1,000 shares for $2.14 per share. The transaction valued at 2,140 led to the insider holds 1,000 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENVB now has a Market Capitalization of 6.42M and an Enterprise Value of -648.99k.
Stock Price History:
Over the past 52 weeks, ENVB has reached a high of $6.98, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.0675, while the 200-Day Moving Average is calculated to be 2.0710.
Shares Statistics:
It appears that ENVB traded 3.52M shares on average per day over the past three months and 19.52M shares per day over the past ten days. A total of 2.74M shares are outstanding, with a floating share count of 2.27M. Insiders hold about 17.28% of the company’s shares, while institutions hold 17.86% stake in the company. Shares short for ENVB as of Feb 29, 2024 were 95.06k with a Short Ratio of 0.03, compared to 22.95k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.47% and a Short% of Float of 3.51%.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1.54 for the current quarter, with a high estimate of -$1.5 and a low estimate of -$1.59, while EPS last year was -$2.73. The consensus estimate for the next quarter is -$1.28, with high estimates of -$1.28 and low estimates of -$1.28.
Analysts are recommending an EPS of between -$8.1 and -$8.24 for the fiscal current year, implying an average EPS of -$8.17. EPS for the following year is -$2.65, with 2 analysts recommending between -$1.87 and -$3.44.
